Outcomes of patients over 70 years treated with brexu-cel for R/R mantle cell lymphoma: a study from the CTIWP of EBMT.

Blood Adv · 2026 · PMC13141491 · PMID 41779968

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

showed a trendP = .051so close (0.05 < p ≤ 0.1)

Disease status at CAR T-cell infusion showed a trend toward inferior PFS (HR, 1.58; P = .051).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.